Email ID
Password
Scrip   
Sandoz blazes biosimilar trail in Japan
06 October 2009
Ian Haydock

Sandoz has become the first company to launch a therapeutic biosimilar in Japan with the introduction of Somatropin BS, its version of Pfizer's recombinant human growth hormone Genotropin.

The product was approved in the country in June for the same range of indications as Genotropin,...



Please Login to read the full article.
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36